Clinical

Dataset Information

0

BMS-247550 in Treating Patients With Advanced Cancers

ABSTRACT: Phase I trial to study the effectiveness of BMS-247550 in treating patients who have malignant solid tumors or lymphoma. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.

DISEASE(S): Small Intestine Cancer,Angioimmunoblastic T-cell Lymphoma,Lymphoma,Intestinal Neoplasms,Unspecified Adult Solid Tumor, Protocol Specific

PROVIDER: 2005268 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Json Xml

Similar Datasets

Clinical BMS-247550 in Treating Patients With Metastatic Colorectal Cancer
| 2007345 | ecrin-mdr-crc
Clinical BMS-247550 in Treating Patients With Recurrent or Metastatic Colorectal Cancer
| 2006586 | ecrin-mdr-crc
Clinical 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Advanced Epithelial Cancer, Malignant Lymphoma, or Sarcoma
| 2003652 | ecrin-mdr-crc
Transcriptomics BMS-470539 on human synovial fibroblasts
2019-12-16 | GSE98658 | GEO
Genomics Methanosphaera sp. BMS
| PRJNA310024 | ENA
Clinical PS-341 in Treating Patients With Advanced Solid Tumors or Lymphoma
| 2003447 | ecrin-mdr-crc
Clinical ZD0473 and Doxorubicin in Treating Patients With Advanced Solid Tumors or Lymphoma
| 2006171 | ecrin-mdr-crc
Clinical 17-Dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG) in Treating Patients With an Advanced Solid Tumor or Lymphoma
| 2011214 | ecrin-mdr-crc
Clinical Irinotecan Plus Cyclosporine and Phenobarbital in Treating Patients With Solid Tumors or Lymphoma
| 2002394 | ecrin-mdr-crc
Transcriptomics Effect of BMS-582949 treatment on gene expression in osteoclasts
2024-02-29 | GSE249860 | GEO